Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Company Description

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd., engages in the research, development, manufacture, and sale of biopharmaceutical products in the People's Republic of China.

It offers photodynamic technology drugs, such as aminolevulinic acid hydrochloride and hemoporfin for Injection; doxorubicin liposome under the Libord brand; genetic engineering drugs; and oral solid preparation technology drugs.

The company was founded in 1996 and is based in Shanghai, the People's Republic of China.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.

Country	China
Founded	1996
Industry	Drug Manufacturers - Specialty & Generic
Sector	Healthcare
Employees	876
CEO	Da Jun Zhao

Contact Details

Address: Zhangjiang Hi-Tech Park Shanghai, 201210 China
Phone	86 21 5895 3355
Website	fd-zj.com

Stock Details

Ticker Symbol	1349
Exchange	Hong Kong Stock Exchange
Fiscal Year	January - December
Reporting Currency	CNY
ISIN Number	CNE1000000W4
SIC Code	2836

Key Executives

Name	Position
Da Jun Zhao	Co-Founder, GM and Executive Chairman
Jun Li	Co-Founder and Deputy GM
Xue Yan ACCA, CIA, CICPA, FCCA, HKICPA	Chief Financial Officer, Deputy GM, Company Secretary and Executive Director
Dai Qing Yu	Deputy General Manager
Yu Chen	Deputy General Manager
Lei Qin	Deputy General Manager
Wen Zhang	Accounting Supervisor
Luo Chun Wang	Core Technical Personnel
Xiaowen Li	Deputy General Manager
Jian Ping Jiang	Core Technical Personnel